Usefulness of Interleukin-1 Blockade in Autoinflammatory Diseases

Overview

Journal Reumatologia

Publisher Termedia

Specialty Rheumatology

Date 2024 May 27

PMID 38799781

Authors

Alenka Gagro

Affiliations

Soon will be listed here.

References

Romano M, Arici Z, Piskin D, Alehashemi S, Aletaha D, Barron K . The 2021 EULAR/American College of Rheumatology points to consider for diagnosis, management and monitoring of the interleukin-1 mediated autoinflammatory diseases: cryopyrin-associated periodic syndromes, tumour necrosis factor receptor-associated.... Ann Rheum Dis. 2022; 81(7):907-921. DOI: 10.1136/annrheumdis-2021-221801. View

Shakoory B, Geerlinks A, Wilejto M, Kernan K, Hines M, Romano M . The 2022 EULAR/ACR Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (HLH/MAS). Arthritis Rheumatol. 2023; 75(10):1714-1732. PMC: 11040593. DOI: 10.1002/art.42636. View

Mantovani A, Dinarello C, Molgora M, Garlanda C . Interleukin-1 and Related Cytokines in the Regulation of Inflammation and Immunity. Immunity. 2019; 50(4):778-795. PMC: 7174020. DOI: 10.1016/j.immuni.2019.03.012. View

Rosina S, Rebollo-Gimenez A, Consolaro A, Ravelli A . Treat-to-Target in Pediatric Rheumatic Diseases. Curr Rheumatol Rep. 2023; 25(11):226-235. DOI: 10.1007/s11926-023-01112-x. View

Sun H, Van L, Floch D, Jiang X, Klein U, Abrams K . Pharmacokinetics and Pharmacodynamics of Canakinumab in Patients With Systemic Juvenile Idiopathic Arthritis. J Clin Pharmacol. 2016; 56(12):1516-1527. DOI: 10.1002/jcph.754. View

Malcova H, Strizova Z, Milota T, Striz I, Sediva A, Cebecauerova D . IL-1 Inhibitors in the Treatment of Monogenic Periodic Fever Syndromes: From the Past to the Future Perspectives. Front Immunol. 2021; 11:619257. PMC: 7884884. DOI: 10.3389/fimmu.2020.619257. View

Fields J, Gunther S, Sundberg E . Structural Basis of IL-1 Family Cytokine Signaling. Front Immunol. 2019; 10:1412. PMC: 6596353. DOI: 10.3389/fimmu.2019.01412. View

Broderick L, Hoffman H . IL-1 and autoinflammatory disease: biology, pathogenesis and therapeutic targeting. Nat Rev Rheumatol. 2022; 18(8):448-463. PMC: 9210802. DOI: 10.1038/s41584-022-00797-1. View

Ehlers L, Rolfes E, Lieber M, Muller D, Lainka E, Gohar F . Treat-to-target strategies for the management of familial Mediterranean Fever in children. Pediatr Rheumatol Online J. 2023; 21(1):108. PMC: 10521475. DOI: 10.1186/s12969-023-00875-y. View

10.

Saunders B, Kuijpers M, Sloan J, Gertner E . Continuous IV infusion of anakinra. Front Pharmacol. 2023; 14:1162742. PMC: 10203171. DOI: 10.3389/fphar.2023.1162742. View

11.

Saper V, Chen G, Deutsch G, Guillerman R, Birgmeier J, Jagadeesh K . Emergent high fatality lung disease in systemic juvenile arthritis. Ann Rheum Dis. 2019; 78(12):1722-1731. PMC: 7065839. DOI: 10.1136/annrheumdis-2019-216040. View

12.

Gaballa J, Falkesgaard Hojen J, de Graaf D, Amo-Aparicio J, Marchetti C, Cavalli G . International nomenclature guidelines for the IL-1 family of cytokines and receptors. Nat Immunol. 2024; 25(4):581-582. DOI: 10.1038/s41590-024-01777-1. View

13.

Dinarello C, Goldin N, Wolff S . Demonstration and characterization of two distinct human leukocytic pyrogens. J Exp Med. 1974; 139(6):1369-81. PMC: 2139679. DOI: 10.1084/jem.139.6.1369. View